Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study

OBJECTIVES: Prevalence of metabolic syndrome (MS) is ~25% and it is currently becoming prevalent in children also. India is estimated to have the maximum number of patients of MS in the world. As insulin resistance is an integral part of MS and the rate of secondary sulfonylurea failure (SSUF) is al...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Rajiv, Gupta, Anita, Gupta, Rajinder Singh, Gupta, Kapil
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043342/
https://www.ncbi.nlm.nih.gov/pubmed/21350615
http://dx.doi.org/10.4103/0976-500X.72349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043342/
https://www.ncbi.nlm.nih.gov/pubmed/21350615
http://dx.doi.org/10.4103/0976-500X.72349

Ejemplares similares